Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$206K Buy
8,568
+500
+6% +$13.1K 0.05% 164
2026
Q1
$227K Sell
8,068
-670
-8% -$17.8K 0.06% 152
2025
Q4
$218K Sell
8,738
-1,112
-11% -$28K 0.06% 150
2025
Q3
$240K Buy
9,850
+670
+7% +$16.5K 0.07% 151
2025
Q2
$235K Sell
9,180
-200
-2% -$4.66K 0.07% 157
2025
Q1
$238K Sell
9,380
-563
-6% -$14.7K 0.08% 149
2024
Q4
$263K Buy
+9,943
New +$270K 0.09% 138

Other funds holding PFE

Umpqua Bank's PFE Position: Q2 2026 in Review

Umpqua Bank increased its Pfizer (PFE) stake by 6.2% in Q2 2026, buying an estimated $13.1K and bringing the position to 8,568 shares worth $206K. The position accounts for 0.05% of the portfolio, ranked #164.

Umpqua Bank first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $263K in Q4 2024. 2,790 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Umpqua Bank held 8,568 shares of Pfizer worth $206K as of Q2 2026.
  • Umpqua Bank bought 500 Pfizer shares in Q2 2026, an estimated $13.1K.
  • Pfizer made up 0.05% of Umpqua Bank's portfolio in Q2 2026, its #164 holding.
  • Umpqua Bank first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Umpqua Bank's Pfizer position peaked at $263K in Q4 2024.
  • 2,790 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Umpqua Bank's 13F filing for Q2 2026, filed 24 Jul 2026.